688068 热景生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.768-7.785-6.3980.86330.580
总资产报酬率 ROA (%)-2.171-6.616-5.9450.77425.046
投入资产回报率 ROIC (%)-2.455-7.277-6.2970.84428.652

边际利润分析
销售毛利率 (%)52.50557.57255.50557.12753.711
营业利润率 (%)-70.882-65.427-43.7733.41230.672
息税前利润/营业总收入 (%)-69.487-68.539-50.142-5.07429.290
净利润/营业总收入 (%)-71.248-63.880-45.8033.05126.012

收益指标分析
经营活动净收益/利润总额(%)107.74094.85970.829-302.162117.095
价值变动净收益/利润总额(%)-2.652-8.570-5.295-157.9721.015
营业外收支净额/利润总额(%)0.5200.8901.013-24.724-1.454

偿债能力分析
流动比率 (X)6.7376.4394.5934.4673.517
速动比率 (X)6.4676.1194.2923.7373.215
资产负债率 (%)16.15916.4568.9745.75613.992
带息债务/全部投入资本 (%)0.7441.8631.4000.7562.153
股东权益/带息债务 (%)11,964.5384,742.6367,007.25813,052.2494,497.771
股东权益/负债合计 (%)486.906475.1251,019.0431,638.419611.307
利息保障倍数 (X)-39.34727.1518.4680.650-31.106

营运能力分析
应收账款周转天数 (天)97.80493.09842.07340.6046.727
存货周转天数 (天)113.468172.809176.785223.36745.142